The Latest Cardiac and Vascular News
– Acceleron expects to report approximately $32.0 million in royalty revenue for Q3 2021 from approximately $160 million in net sales of REBLOZYL® (luspatercept-aamt) as reported by Bristol Myers Squibb – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Acceleron Pharma Inc. (Nasdaq:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics […]
SILVER SPRING, Md., Oct. 25, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it was informed by Medtronic that, after conducting a thorough review of […]
Ad hoc announcement pursuant to Art. 53 LR Q3 net sales grew +5% (cc¹, +6% USD) Innovative Medicines grew +7% (cc, +8% USD) Strong performance of key growth drivers: Entresto (+44% cc), Cosentyx (+22% cc), Kesimpta (USD 109 million), Jakavi (+26% cc), Zolgensma (+28% cc), Promacta/Revolade (+18% cc) and Kisqali (+27% cc) Sandoz declined -2% (cc, -1% USD), affected by continued pricing pressures. Ex-US […]
CLEVELAND–(BUSINESS WIRE)–ScottCare Cardiovascular Solutions (www.scottcare.com) announced that it has signed an agreement with Ninety One Holding, Inc. (www.91.life) to become a principal distributor for Ninety One’s cloud software platform for cardiac implanted device monitoring, effectively expanding the partnership between the two firms. Currently, ScottCare’s 24/7 remote cardiac monitoring service, Ambucor, […]
-The acquisition and funding will support commercialization of the company’s personalized decision support solutions to serve millions of seniors and their caregivers via mobile applications, with a special focus on Medicare Advantage ASHEVILLE, N.C., Oct. 21, 2021 /PRNewswire/ — ilumivu, Inc., a pioneer in predictive and personalized healthcare intervention software utilized at university […]
GENT, Belgium–(BUSINESS WIRE)–FEops, a cloud-based digital health player in the structural heart space, is glad to announce the nomination of Euan Thomson as a board member to its Board of Directors. “We are delighted to welcome Euan to the FEops Board of Directors. His wealth of knowledge and extensive expertise […]
– Third-quarter sales growth of 23.4 percent; organic sales growth of 22.4 percent – GAAP diluted EPS from continuing operations growth of 69.6 percent; adjusted diluted EPS growth of 42.9 percent – Global COVID-19 testing-related sales were $1.9 billion in the third quarter – Excluding COVID-19 testing-related sales, third-quarter sales […]
CINCINNATI, Oct. 19, 2021 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) today announced the appointment of Mason W. Freeman, M.D., as Executive Vice President, Clinical Development responsible for leading all clinical development at CinCor. “Mason will be guiding the clinical development programs for CIN-107 for multiple potential indications, including hypertension,” […]
Nuwellis recognized as a Minnesota company that has shown exceptional progress and success in foreign markets EDEN PRAIRIE, Minn., Oct. 19, 2021 (GLOBE NEWSWIRE) — Nuwellis, Inc. (NASDAQ: NUWE) was honored last week with the 2021 Governor’s International Trade Award by Minnesota Governor Tim Walz. This award honors Minnesota companies that are […]
Veteran Silicon Valley Technology Investors Lead Funding Round to Further Develop and Market Cardisio’s Unique Method for Heart Disease Screening FRANKFURT, Germany, Oct. 19, 2021 /PRNewswire/ — Cardisio GmbH, developers of the world’s first non-invasive, highly accurate screening method for heart diseases, today announced completion of its largest investment round to date. […]
